Yang Huang
Stock Analyst at J.P. Morgan
(4.86)
# 364
Out of 5,125 analysts
123
Total ratings
68.6%
Success rate
36.8%
Average return
Main Sectors:
Stocks Rated by Yang Huang
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 1548 Genscript Biotech Corporation | Reiterated: Buy | $23.00 → $41.00 | $32.00 | +28.13% | 4 | Sep 17, 2026 | |
| HKG: 1801 Innovent Biologics, Inc. | Reiterated: Buy | $117.00 → $140.00 | $88.50 | +58.19% | 20 | Aug 27, 2026 | |
| HKG: 9995 RemeGen Co., Ltd. | Reiterated: Buy | $129.00 | $70.70 | +82.46% | 14 | Aug 6, 2026 | |
| HKG: 2359 WuXi AppTec Co., Ltd. | Reiterated: Buy | $138.00 → $150.00 | $202.00 | -25.74% | 11 | Mar 26, 2026 | |
| HKG: 6990 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Reiterated: Buy | $499.00 → $545.00 | $465.80 | +17.00% | 2 | Nov 24, 2025 | |
| HKG: 1877 Shanghai Junshi Biosciences Co., Ltd. | Reiterated: Sell | $18.00 → $20.00 | $16.40 | n/a | 9 | Oct 30, 2025 | |
| HKG: 3347 Hangzhou Tigermed Consulting Co., Ltd | Reiterated: Sell | $37.00 → $38.00 | $38.22 | n/a | 8 | Oct 29, 2025 | |
| HKG: 3692 Hansoh Pharmaceutical Group Company Limited | Initiated Coverage: Buy | $43.00 | $34.46 | n/a | 1 | Sep 25, 2025 | |
| HKG: 1276 Jiangsu Hengrui Pharmaceuticals Co.,Ltd | Initiated Coverage: Hold | $78.00 | $50.55 | n/a | 1 | Sep 23, 2025 | |
| HKG: 9926 Akeso, Inc. | Reiterated: Buy | $99.00 → $166.00 | $88.70 | n/a | 11 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36.00 → $37.00 | $49.62 | n/a | 10 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46.00 → $74.00 | $73.15 | n/a | 6 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52.00 → $93.00 | $29.96 | n/a | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $84.00 → $80.00 | $43.00 | n/a | 2 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $186.00 → $183.60 | $259.60 | n/a | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $3.40 | $1.56 | n/a | 1 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $217 → $64 | $26.43 | n/a | 3 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $26.50 | $5.85 | n/a | 1 | Jan 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $4.80 → $3.00 | $1.66 | n/a | 3 | Jan 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14.00 | $8.57 | n/a | 4 | Aug 31, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $18.00 | $10.54 | n/a | 2 | Aug 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $9.00 → $11.00 | $15.13 | n/a | 2 | Jun 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $230 → $169 | $424.00 | n/a | 4 | Mar 26, 2020 |
Genscript Biotech Corporation
Sep 17, 2026
Reiterated: Buy
Price Target: $23.00 → $41.00
Current: $32.00
Upside: +28.13%
Innovent Biologics, Inc.
Aug 27, 2026
Reiterated: Buy
Price Target: $117.00 → $140.00
Current: $88.50
Upside: +58.19%
RemeGen Co., Ltd.
Aug 6, 2026
Reiterated: Buy
Price Target: $129.00
Current: $70.70
Upside: +82.46%
WuXi AppTec Co., Ltd.
Mar 26, 2026
Reiterated: Buy
Price Target: $138.00 → $150.00
Current: $202.00
Upside: -25.74%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Nov 24, 2025
Reiterated: Buy
Price Target: $499.00 → $545.00
Current: $465.80
Upside: +17.00%
Shanghai Junshi Biosciences Co., Ltd.
Oct 30, 2025
Reiterated: Sell
Price Target: $18.00 → $20.00
Current: $16.40
Upside: n/a
Hangzhou Tigermed Consulting Co., Ltd
Oct 29, 2025
Reiterated: Sell
Price Target: $37.00 → $38.00
Current: $38.22
Upside: n/a
Hansoh Pharmaceutical Group Company Limited
Sep 25, 2025
Initiated Coverage: Buy
Price Target: $43.00
Current: $34.46
Upside: n/a
Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Sep 23, 2025
Initiated Coverage: Hold
Price Target: $78.00
Current: $50.55
Upside: n/a
Akeso, Inc.
Aug 27, 2025
Reiterated: Buy
Price Target: $99.00 → $166.00
Current: $88.70
Upside: n/a
Aug 21, 2025
Reiterated: Buy
Price Target: $36.00 → $37.00
Current: $49.62
Upside: n/a
Aug 14, 2025
Reiterated: Buy
Price Target: $46.00 → $74.00
Current: $73.15
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $52.00 → $93.00
Current: $29.96
Upside: n/a
May 16, 2023
Reiterated: Buy
Price Target: $84.00 → $80.00
Current: $43.00
Upside: n/a
Mar 7, 2023
Reiterated: Buy
Price Target: $186.00 → $183.60
Current: $259.60
Upside: n/a
Feb 22, 2023
Upgraded: Buy
Price Target: $3.40
Current: $1.56
Upside: n/a
Nov 14, 2022
Reiterated: Buy
Price Target: $217 → $64
Current: $26.43
Upside: n/a
Jan 6, 2022
Downgraded: Sell
Price Target: $26.50
Current: $5.85
Upside: n/a
Jan 6, 2022
Downgraded: Sell
Price Target: $4.80 → $3.00
Current: $1.66
Upside: n/a
Aug 31, 2021
Reiterated: Buy
Price Target: $14.00
Current: $8.57
Upside: n/a
Aug 27, 2021
Reiterated: Hold
Price Target: $18.00
Current: $10.54
Upside: n/a
Jun 29, 2021
Downgraded: Hold
Price Target: $9.00 → $11.00
Current: $15.13
Upside: n/a
Mar 26, 2020
Reiterated: Buy
Price Target: $230 → $169
Current: $424.00
Upside: n/a